Targeting STAT3 has therapeutic potential to regain nilotinib response in parental and resistant chronic myeloid leukemia cells


TEZCANLI KAYMAZ B., SELVİ GÜNEL N., BOZOK ÇETİNTAŞ V., ADAN A. , BARAN Y. , GÜNDÜZ C., ...More

EACR-Sponsored 3rd Anticancer Agent Development Congress, İzmir, Turkey, 18 - 19 May 2015, pp.182

  • Publication Type: Conference Paper / Full Text
  • City: İzmir
  • Country: Turkey
  • Page Numbers: pp.182